Community-based active case-finding interventions for tuberculosis: a systematic review.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
05 2021
Historique:
received: 07 12 2020
revised: 03 02 2021
accepted: 08 02 2021
pubmed: 26 3 2021
medline: 6 5 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Community-based active case-finding interventions might identify and treat more people with tuberculosis disease than standard case detection. We aimed to assess whether active case-finding interventions can affect tuberculosis epidemiology in the wider community. We did a systematic review by searching PubMed, Embase, Scopus, and Cochrane Library for studies that compared tuberculosis case notification rates, tuberculosis disease prevalence, or tuberculosis infection prevalence or incidence in children, between populations exposed and unexposed to active case-finding interventions. We included studies published in English between Jan 1, 1980, and April 13, 2020. Studies of active case-finding in the general population, in populations perceived to be at high risk for tuberculosis, and in closed settings were included, whereas studies of tuberculosis screening at health-care facilities, among household contacts, or among children only, and studies that screened fewer than 1000 people were excluded. To estimate effectiveness, we extracted or calculated case notification rates, prevalence of tuberculosis disease, and incidence or prevalence of tuberculosis infection in children, and compared ratios of these outcomes between groups that were exposed or not exposed to active case-finding interventions. 27 883 abstracts were screened and 988 articles underwent full text review. 28 studies contributed data for analysis of tuberculosis case notifications, nine for prevalence of tuberculosis disease, and two for incidence or prevalence of tuberculosis infection in children. In one cluster-randomised trial in South Africa and Zambia, an active case-finding intervention based on community mobilisation and sputum drop-off did not affect tuberculosis prevalence, whereas, in a cluster-randomised trial in Vietnam, an active case-finding intervention based on sputum tuberculosis tests for everyone reduced tuberculosis prevalence in the community. We found inconsistent, low-quality evidence that active case-finding might increase the number of cases of tuberculosis notified in populations with structural risk factors for tuberculosis. Community-based active case-finding for tuberculosis might be effective in changing tuberculosis epidemiology and thereby improving population health if delivered with high coverage and intensity. If possible, active case-finding projects should incorporate a well designed, robust evaluation to contribute to the evidence base and help elucidate which delivery methods and diagnostic strategies are most effective. WHO Global TB Programme.

Sections du résumé

BACKGROUND
Community-based active case-finding interventions might identify and treat more people with tuberculosis disease than standard case detection. We aimed to assess whether active case-finding interventions can affect tuberculosis epidemiology in the wider community.
METHODS
We did a systematic review by searching PubMed, Embase, Scopus, and Cochrane Library for studies that compared tuberculosis case notification rates, tuberculosis disease prevalence, or tuberculosis infection prevalence or incidence in children, between populations exposed and unexposed to active case-finding interventions. We included studies published in English between Jan 1, 1980, and April 13, 2020. Studies of active case-finding in the general population, in populations perceived to be at high risk for tuberculosis, and in closed settings were included, whereas studies of tuberculosis screening at health-care facilities, among household contacts, or among children only, and studies that screened fewer than 1000 people were excluded. To estimate effectiveness, we extracted or calculated case notification rates, prevalence of tuberculosis disease, and incidence or prevalence of tuberculosis infection in children, and compared ratios of these outcomes between groups that were exposed or not exposed to active case-finding interventions.
RESULTS
27 883 abstracts were screened and 988 articles underwent full text review. 28 studies contributed data for analysis of tuberculosis case notifications, nine for prevalence of tuberculosis disease, and two for incidence or prevalence of tuberculosis infection in children. In one cluster-randomised trial in South Africa and Zambia, an active case-finding intervention based on community mobilisation and sputum drop-off did not affect tuberculosis prevalence, whereas, in a cluster-randomised trial in Vietnam, an active case-finding intervention based on sputum tuberculosis tests for everyone reduced tuberculosis prevalence in the community. We found inconsistent, low-quality evidence that active case-finding might increase the number of cases of tuberculosis notified in populations with structural risk factors for tuberculosis.
INTERPRETATION
Community-based active case-finding for tuberculosis might be effective in changing tuberculosis epidemiology and thereby improving population health if delivered with high coverage and intensity. If possible, active case-finding projects should incorporate a well designed, robust evaluation to contribute to the evidence base and help elucidate which delivery methods and diagnostic strategies are most effective.
FUNDING
WHO Global TB Programme.

Identifiants

pubmed: 33765456
pii: S2468-2667(21)00033-5
doi: 10.1016/S2468-2667(21)00033-5
pmc: PMC8082281
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e283-e299

Subventions

Organisme : Wellcome Trust
ID : 200901/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206575/Z/17/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : K23 AI140918
Pays : United States
Organisme : Medical Research Council
ID : MR/N020618/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests JEG, HA, and ELC are authors of trials included in this systematic review. HA and ELC are members of the WHO TB Screening Guideline Development Group. JEG, HA, ELC, and PM have received research grants to their institutions for projects evaluating community-based active case-finding. All other authors declare no competing interests.

Références

PLoS One. 2019 Dec 12;14(12):e0226160
pubmed: 31830092
Public Health Action. 2015 Dec 21;5(4):246-8
pubmed: 26767178
PLoS One. 2014 Mar 27;9(3):e92754
pubmed: 24675985
BMC Public Health. 2013 Oct 20;13:983
pubmed: 24139204
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
PLoS One. 2016 Nov 29;11(11):e0165813
pubmed: 27898665
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Lancet Glob Health. 2019 Apr;7(4):e482-e491
pubmed: 30824364
Int J Tuberc Lung Dis. 2014 Sep;18(9):1099-104
pubmed: 25189559
Int J Infect Dis. 2019 Nov;88:34-40
pubmed: 31374346
Indian J Tuberc. 2019 Oct;66(4):480-486
pubmed: 31813435
Bull World Health Organ. 2006 Feb;84(2):112-9
pubmed: 16501728
Public Health Action. 2017 Mar 21;7(1):67-70
pubmed: 28775946
BMJ Glob Health. 2017 Nov 2;2(4):e000390
pubmed: 29209537
Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593
pubmed: 24448973
Int J Infect Dis. 2018 May;70:93-100
pubmed: 29476901
PLoS One. 2014 Apr 11;9(4):e94603
pubmed: 24728010
Am J Respir Crit Care Med. 2007 Jul 15;176(2):201-7
pubmed: 17413123
Lancet. 2013 Oct 5;382(9899):1183-94
pubmed: 23915882
PLoS One. 2016 Oct 4;11(10):e0163813
pubmed: 27701446
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):750-755
pubmed: 31315709
Tuberc Res Treat. 2016;2016:8020745
pubmed: 27668093
Lancet HIV. 2018 Sep;5(9):e515-e523
pubmed: 30139576
Int J Tuberc Lung Dis. 2013 Apr;17(4):432-46
pubmed: 23485377
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Clin Infect Dis. 2020 Sep 16;:
pubmed: 32936877
Int J Tuberc Lung Dis. 2014 Sep;18(9):1105-7
pubmed: 25189560
Int J Tuberc Lung Dis. 2010 Jun;14(6):720-6
pubmed: 20487610
PLoS One. 2009;4(5):e5443
pubmed: 19424460
BMC Health Serv Res. 2018 Dec 12;18(1):954
pubmed: 30541533
Thorax. 2011 Feb;66(2):134-9
pubmed: 21098802
J Correct Health Care. 2016 Oct;22(4):322-330
pubmed: 27742856
Indian J Tuberc. 2015 Apr;62(2):121-3
pubmed: 26117484
Int J Tuberc Lung Dis. 2015 Apr;19(4):463-8
pubmed: 25860003
Int J Tuberc Lung Dis. 1999 Mar;3(3):177-8
pubmed: 10094315
Indian J Tuberc. 2013 Jul;60(3):168-76
pubmed: 24000495
Bull World Health Organ. 2015 Feb 1;93(2):93-101
pubmed: 25883402
Am J Public Health. 2013 Jul;103(7):1292-300
pubmed: 23078465
Public Health Action. 2012 Dec 21;2(4):152-6
pubmed: 26392976
Lancet. 2010 Oct 9;376(9748):1244-53
pubmed: 20923715
J Epidemiol Glob Health. 2019 Dec;9(4):233-242
pubmed: 31854164
Infect Dis Poverty. 2019 Oct 29;8(1):92
pubmed: 31661031
Am J Prev Med. 1999 Aug;17(2):108-13
pubmed: 10490052

Auteurs

Rachael M Burke (RM)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. Electronic address: rachael.burke@lshtm.ac.uk.

Marriott Nliwasa (M)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Helse Nord Tuberculosis Initiative, College of Medicine, University of Malawi, Blantyre, Malawi.

Helena R A Feasey (HRA)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Lelia H Chaisson (LH)

Division of Infectious Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

Jonathan E Golub (JE)

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Fahd Naufal (F)

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Adrienne E Shapiro (AE)

Department of Global Health and Department of Medicine, University of Washington, Seattle, WA, USA.

Maria Ruperez (M)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Lily Telisinghe (L)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Zambart, University of Zambia School of Public Health, Ridgeway, Zambia.

Helen Ayles (H)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Zambart, University of Zambia School of Public Health, Ridgeway, Zambia.

Elizabeth L Corbett (EL)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Peter MacPherson (P)

Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Liverpool School of Tropical Medicine, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH